Carsten Grüllich

2PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 05, 2020
Patient-Reported Outcomes from the Phase III Randomized IMmotion151 Trial: Atezolizumab + Bevacizumab versus Sunitinib in Treatment-Naïve Metastatic Renal Cell Carcinoma.

Michael B Atkins, Brian I Rini, Robert J Motzer

Pageof 1

Frequent Collaborators

2 joint publications

Robert J Motzer

2 joint publications

Howard Gurney